These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29296393)

  • 21. A comparison between accelerated hypofractionation and stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung cancer (NSCLC): Results of a propensity score-matched analysis.
    Chiang A; Thibault I; Warner A; Rodrigues G; Palma D; Soliman H; Jain S; Poon I; Cheung P
    Radiother Oncol; 2016 Mar; 118(3):478-84. PubMed ID: 26795773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive factors of symptomatic radiation pneumonitis in primary and metastatic lung tumors treated with stereotactic ablative body radiotherapy.
    Kim K; Lee J; Cho Y; Chung SY; Lee JJB; Lee CG; Cho J
    Radiat Oncol J; 2017 Jun; 35(2):163-171. PubMed ID: 28712275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single fraction spine stereotactic ablative body radiotherapy with volumetric modulated arc therapy.
    Gestaut MM; Thawani N; Kim S; Gutti VR; Jhavar S; Deb N; Morrow A; Ward RA; Huang JH; Patel M
    J Neurooncol; 2017 May; 133(1):165-172. PubMed ID: 28409420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereotactic Ablative Radiotherapy (SABR) in Patients with Medically Inoperable Peripheral Early Stage Lung Cancer: Outcomes for the First UK SABR Cohort.
    Murray L; Ramasamy S; Lilley J; Snee M; Clarke K; Musunuru HB; Needham A; Turner R; Sangha V; Flatley M; Franks K
    Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):4-12. PubMed ID: 26474546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adrenal Insufficiency following Stereotactic Ablative Radiotherapy (SAbR) of Adrenal Gland Metastases.
    Hamidi O; Miljanic M; Tumyan G; Christie A; Mirfakhraee S; Ali S; Dohopolski M; Gottumukkala S; Brugarolas J; Timmerman R; Hannan R
    Cancers (Basel); 2024 Sep; 16(18):. PubMed ID: 39335112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome and toxicity of hypofractionated image-guided SABR for spinal oligometastases.
    Billiet C; Joye I; Mercier C; Depuydt L; De Kerf G; Vermeulen P; Van Laere S; Van de Kelft E; Meijnders P; Verellen D; Dirix P
    Clin Transl Radiat Oncol; 2020 Sep; 24():65-70. PubMed ID: 32642561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lung Metastases Treated With Stereotactic Ablative Radiation Therapy in Oligometastatic Colorectal Cancer Patients: Outcomes and Prognostic Factors After Long-Term Follow-Up.
    Agolli L; Bracci S; Nicosia L; Valeriani M; De Sanctis V; Osti MF
    Clin Colorectal Cancer; 2017 Mar; 16(1):58-64. PubMed ID: 27522627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereotactic ablative radiotherapy for adrenal gland metastases: Factors influencing outcomes, patterns of failure, and dosimetric thresholds for toxicity.
    Chance WW; Nguyen QN; Mehran R; Welsh JW; Gomez DR; Balter P; Komaki R; Liao Z; Chang JY
    Pract Radiat Oncol; 2017; 7(3):e195-e203. PubMed ID: 27743801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer.
    Widder J; Postmus D; Ubbels JF; Wiegman EM; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e291-7. PubMed ID: 21640503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic Ablative Radiotherapy for the Management of Liver Metastases from Neuroendocrine Neoplasms: A Preliminary Study.
    Hudson JM; Chung HT; Chu W; Taggar A; Davis LE; Hallet J; Law CHL; Singh S; Myrehaug S
    Neuroendocrinology; 2022; 112(2):153-160. PubMed ID: 33530088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereotactic ablative radiotherapy for malignant mediastinal and hilar lymphadenopathy: a systematic review.
    Tjong MC; Malik NH; Chen H; Boldt RG; Li G; Cheung P; Poon I; Ung YC; Tsao M; Louie AV
    J Thorac Dis; 2020 May; 12(5):2280-2287. PubMed ID: 32642133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate-specific membrane antigen-positron emission tomography/computed tomography (PSMA-PET/CT)-guided stereotactic ablative body radiotherapy for oligometastatic prostate cancer: a single-institution experience and review of the published literature.
    Ong WL; Koh TL; Lim Joon D; Chao M; Farrugia B; Lau E; Khoo V; Lawrentschuk N; Bolton D; Foroudi F
    BJU Int; 2019 Nov; 124 Suppl 1():19-30. PubMed ID: 31507035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and Effectiveness of Stereotactic Ablative Radiotherapy for Ultra-Central Lung Lesions: A Systematic Review.
    Chen H; Laba JM; Zayed S; Boldt RG; Palma DA; Louie AV
    J Thorac Oncol; 2019 Aug; 14(8):1332-1342. PubMed ID: 31075543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NaF PET/CT for response assessment of prostate cancer bone metastases treated with single fraction stereotactic ablative body radiotherapy.
    Hardcastle N; Hofman MS; Lee CY; Callahan J; Selbie L; Foroudi F; Shaw M; Chander S; Lim A; Chesson B; Murphy DG; Kron T; Siva S
    Radiat Oncol; 2019 Sep; 14(1):164. PubMed ID: 31488175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereotactic ablative radiotherapy for locally advanced non-small cell lung cancer: A systematic review and meta-analysis.
    Viani GA; Gouveia AG; Louie AV; Arcidiacono F; Simone CB; Tsakiridis T; Carolina Hamamura A; Anselmo P; Moraes FY
    Radiother Oncol; 2024 Dec; 201():110439. PubMed ID: 39032835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereotactic body radiotherapy or stereotactic ablative radiotherapy versus surgery for patients with T1-3N0M0 non-small cell lung cancer: a systematic review and meta-analysis.
    Li M; Yang X; Chen Y; Yang X; Dai X; Sun F; Zhang L; Zhan C; Feng M; Wang Q
    Onco Targets Ther; 2017; 10():2885-2892. PubMed ID: 28652770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereotactic ablative body radiotherapy for lung cancer.
    Franks KN; Jain P; Snee MP
    Clin Oncol (R Coll Radiol); 2015 May; 27(5):280-9. PubMed ID: 25746732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of Total En Bloc Spondylectomy versus Stereotactic Ablative Radiotherapy for Single Spinal Metastasis.
    Kang DH; Lee W; Chang BS; Kim H; Chang SY; Hong SH; Kim JH; Son HJ
    Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors associated with pain palliation after spine stereotactic body radiation therapy.
    Puvanesarajah V; Lo SL; Aygun N; Liauw JA; Jusué-Torres I; Lina IA; Hadelsberg U; Elder BD; Bydon A; Bettegowda C; Sciubba DM; Wolinsky JP; Rigamonti D; Kleinberg LR; Gokaslan ZL; Witham TF; Redmond KJ; Lim M
    J Neurosurg Spine; 2015 Nov; 23(5):620-629. PubMed ID: 26230422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity.
    Franzese C; Bonu ML; Comito T; Clerici E; Loi M; Navarria P; Franceschini D; Pressiani T; Rimassa L; Scorsetti M
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2289-2297. PubMed ID: 32524292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.